Home › Funds › De Lisle Partners LLP › UFPT
De Lisle Partners LLP position in UFPT
UFP TECHNOLOGIES INC · Health Care
De Lisle Partners LLP reported holding 74,302 shares of UFPT (UFP TECHNOLOGIES INC) in its Q3 2026 13F filing — a position valued at US$22.1M, representing 2.70% of its reported portfolio and ranking #4 among its reported holdings. De Lisle Partners LLP has disclosed UFPT holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How De Lisle Partners LLP's UFPT position evolved
De Lisle Partners LLP first disclosed a stake in UFPT in Q1 2024 at 47,470 shares (US$12.0M). The position peaked in Q3 2026 at 74,302 shares, worth US$22.1M. Across 11 filings, De Lisle Partners LLP increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 74,302 shares valued at US$22.1M. Notable position changes include a 31% increase in Q3 2024 (shares fell 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 47.47K | $11.98M | New |
| Q2 2024 | 50.97K | $13.42M | Add |
| Q3 2024 | 66.57K | $21.07M | Add |
| Q4 2024 | 67.67K | $16.56M | Add |
| Q1 2025 | 79.80K | $16.11M | Add |
| Q2 2025 | 81.60K | $19.94M | Add |
| Q3 2025 | 76.40K | $15.25M | Reduce |
| Q4 2025 | 74.30K | $16.49M | Reduce |
| Q1 2026 | 74.30K | $14.41M | Hold |
| Q2 2026 | 74.30K | $19.68M | Hold |
| Q3 2026 | 74.30K | $22.07M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UFPT and 13F data
UFPT (UFP TECHNOLOGIES INC) is a Health Care company. 32 other funds we track also report a position in UFPT — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$171.8M), WASATCH ADVISORS LP (US$164.1M), Boston Trust Walden Corp (US$95.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UFPT
- CONGRESS ASSET MANAGEMENT CO 578.77K sh · $171.79M · Q3 2026
- WASATCH ADVISORS LP 552.81K sh · $164.08M · Q3 2026
- Boston Trust Walden Corp 320.34K sh · $95.08M · Q3 2026
- AltraVue Capital, LLC 146.99K sh · $43.63M · Q3 2026
- ASHFORD CAPITAL MANAGEMENT INC 105.02K sh · $27.84M · Q2 2026
- GENEVA CAPITAL MANAGEMENT LLC 89.91K sh · $26.69M · Q3 2026
- NEUMEIER POMA INVESTMENT COUNSEL LLC 78.83K sh · $23.40M · Q3 2026
More on De Lisle Partners LLP
FAQ
How long has De Lisle Partners LLP held UFPT?
De Lisle Partners LLP has disclosed UFPT holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is De Lisle Partners LLP's current position in UFPT?
As of Q3 2026, De Lisle Partners LLP holds 74.30K shares of UFPT (UFP TECHNOLOGIES INC), valued at $22.07M, representing 2.70% of its reported portfolio and ranking #4.
Has De Lisle Partners LLP been buying or selling UFPT?
In the latest 13F filing (Q3 2026), De Lisle Partners LLP held unchanged its position in UFPT. The position peaked in Q3 2026 at 74.30K shares.
Which other funds hold UFPT?
Other major institutional holders of UFPT include CONGRESS ASSET MANAGEMENT CO, WASATCH ADVISORS LP, Boston Trust Walden Corp, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.